| pubmed-article:2072744 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2072744 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:2072744 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:2072744 | lifeskim:mentions | umls-concept:C1159731 | lld:lifeskim |
| pubmed-article:2072744 | lifeskim:mentions | umls-concept:C0812425 | lld:lifeskim |
| pubmed-article:2072744 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:2072744 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:2072744 | pubmed:dateCreated | 1991-8-20 | lld:pubmed |
| pubmed-article:2072744 | pubmed:abstractText | The expression of nucleoside carrier [nitrobenzylmercaptopurine riboside (NBMPR) binding] sites has been related to proliferative fraction in cell lines and in patient myeloid and lymphoid blasts. This correlation was examined in patients with untreated acute myeloid leukemia (AML). Bone marrow blasts were incubated with 8 microM bromodeoxyuridine (BrdUrd) and dual-labeled with propidium iodide and anti-BrdUrd monoclonal antibody. Flow cytometry was used to determine the percentage of cells with detectable BrdUrd incorporation into DNA (%S) and the proliferative fraction (PF = %S+%G2M) in 63 patients; NBMPR binding sites were quantitated in samples from 29 patients. The median %S was 6.1% (range 0.6-25.9%) and the median PF was 13.0% (range 2.4-36.1%), with a median of 7243 NBMPR binding sites per cell (range 1716-27247). In contrast to a previous report which included bone marrow and peripheral blood blasts, %S in marrow blasts did not correlate with NBMPR binding sites per cell (r = 0.005, p = 0.979). Similarly, PF did not correlate with NBMPR sites per cell (r = 0.190, p = 0.325). This lack of correlation between leukemia cell proliferation and NBMPR binding sites per cell suggests that DNA synthesis in AML blasts depends primarily on de novo nucleoside synthesis rather than the usage of salvage pathways. | lld:pubmed |
| pubmed-article:2072744 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2072744 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2072744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2072744 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2072744 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2072744 | pubmed:issn | 0887-6924 | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:PowellB LBL | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:CapizziR LRL | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:WhiteJ CJC | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:LyerlyE SES | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:Rhinehardt-Cl... | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:BrockschmidtJ... | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:GregoryB WBW | lld:pubmed |
| pubmed-article:2072744 | pubmed:author | pubmed-author:ChorleyH MHM | lld:pubmed |
| pubmed-article:2072744 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2072744 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:2072744 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2072744 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2072744 | pubmed:pagination | 598-601 | lld:pubmed |
| pubmed-article:2072744 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:meshHeading | pubmed-meshheading:2072744-... | lld:pubmed |
| pubmed-article:2072744 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2072744 | pubmed:articleTitle | S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells. | lld:pubmed |
| pubmed-article:2072744 | pubmed:affiliation | Comprehensive Cancer Center of Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1082. | lld:pubmed |
| pubmed-article:2072744 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2072744 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2072744 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2072744 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2072744 | lld:pubmed |
